Načítá se...
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
Malignant mesothelioma (MM) is a treatment-resistant tumor originating in the mesothelial lining of the pleura or the abdominal cavity with very limited treatment options. More effective therapeutic approaches are urgently needed to improve the poor prognosis of MM patients. Chimeric Antigen Recepto...
Uloženo v:
| Vydáno v: | Biomark Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7885509/ https://ncbi.nlm.nih.gov/pubmed/33588928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00264-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|